https://clinicaltrials.gov/ct2/show/NCT03976349?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F23%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson’s Disease
DESCRIPTION:
Condition: Parkinson’s Disease
Interventions: Drug: BIIB094; Drug: Placebo
Sponsors: Biogen; Ionis Pharmaceuticals, Inc.
Not yet recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03976349
FIRST POSTED:
Thu, 06 Jun 2019 12:00:00 EDT
LAST UPDATE POSTED:
06/06/19 07:37AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03976349?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F23%2F2019&lupd_d=14&sort=nwst